# A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

> clinical trial · VERIFIED · 2026-06-24

Status: RECRUITING · Sponsor: Exelixis · Condition: Solid Tumor

- Company: Exelixis
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06952010

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.